INTELLIGENT BIO SOLUTIONS INC. Inventory Write-down
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Inventory Write-down of $62.04 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. inventory write-down for the quarter ending 2026-06-30 was $24.73K.
- INTELLIGENT BIO SOLUTIONS INC. inventory write-down for the quarter ending 2026-03-31 was $37.31K.
- INTELLIGENT BIO SOLUTIONS INC. inventory write-down for the quarter ending 2024-06-30 was $397.00, a 86.00% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. inventory write-down for the quarter ending 2024-03-31 was $263.00.
- INTELLIGENT BIO SOLUTIONS INC. inventory write-down for fiscal 2026 was $62.04K.
- INTELLIGENT BIO SOLUTIONS INC. inventory write-down for fiscal 2024 was $69.68K, a 63.26% decline from fiscal 2023.
- INTELLIGENT BIO SOLUTIONS INC. inventory write-down for fiscal 2023 was $189.67K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-06-30 | $24.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $62.04K derived: sum of 2 quarters · filed 2026-08-19 | $62.04K 10-K · filed 2026-08-19 | |
| 2026-03-31 | $37.31K 10-Q · filed 2026-05-13 | $37.31K 10-Q · filed 2026-05-13 | ||
| 2024-06-30 | $397.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $660.00 derived: sum of 2 quarters · filed 2025-08-15 | $1.82K derived: sum of 3 quarters · filed 2025-08-15 | $69.68K 10-K · filed 2025-08-15 |
| 2024-03-31 | $263.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | $1.43K derived: sum of 2 quarters · filed 2025-05-13 | $69.28K 10-Q · filed 2025-05-13 | $72.11K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $69.02K 10-Q · filed 2025-02-13 | $71.85K derived: sum of 3 quarters · filed 2025-02-13 | $70.32K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $67.85K 10-Q · filed 2024-11-07 | $70.69K derived: sum of 2 quarters · filed 2024-11-07 | $69.16K derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | $2.84K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $1.31K derived: sum of 2 quarters · filed 2024-09-18 | $189.67K 10-K · filed 2024-09-18 | |
| 2023-03-31 | -$1.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | $186.83K 10-Q · filed 2024-05-08 | ||
| 2022-12-31 | $188.36K 10-Q · filed 2024-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |